DISA Signs Licensing Deal to Commercialize AI-Powered Cataract Screening Device

MT Newswires

2025/01/09

DISA Limited's (SGX:532) subsidiary, Digital Life Line, has partnered with the National University Hospital (Singapore) and the National University of Singapore to commercialize the Mobile Imaging Device for Anterior Segment (MIDAS), a portable cataract screening device, according to a Wednesday filing with the Tokyo Stock Exchange.

The AI-powered tool, designed for use with smartphones, enables quick, community-based cataract detection, targeting early intervention, the filing said.

Chief Executive Officer Eddie Chng said the device combines AI algorithms with ease of use, delivering results in 10 seconds. The company aims to expand the device's reach regionally.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2502808121"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2502808121\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2502808121?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-09 06:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2502808121","market":"sg","top_or_hot":-1,"title":"DISA Signs Licensing Deal to Commercialize AI-Powered Cataract Screening Device","media":"MT Newswires","content":"<html><body><p> DISA Limited's (SGX:532) subsidiary, Digital Life Line, has partnered with the National University Hospital (Singapore) and the National University of Singapore to commercialize the Mobile Imaging Device for Anterior Segment (MIDAS), a portable cataract screening device, according to a Wednesday filing with the Tokyo Stock Exchange.</p><p>The AI-powered tool, designed for use with smartphones, enables quick, community-based cataract detection, targeting early intervention, the filing said.</p><p>Chief Executive Officer Eddie Chng said the device combines AI algorithms with ease of use, delivering results in 10 seconds. The company aims to expand the device's reach regionally.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DISA Signs Licensing Deal to Commercialize AI-Powered Cataract Screening Device</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDISA Signs Licensing Deal to Commercialize AI-Powered Cataract Screening Device\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1060499803\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires </p>\n<p class=\"h-time\">2025-01-09 06:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> DISA Limited's (SGX:532) subsidiary, Digital Life Line, has partnered with the National University Hospital (Singapore) and the National University of Singapore to commercialize the Mobile Imaging Device for Anterior Segment (MIDAS), a portable cataract screening device, according to a Wednesday filing with the Tokyo Stock Exchange.</p><p>The AI-powered tool, designed for use with smartphones, enables quick, community-based cataract detection, targeting early intervention, the filing said.</p><p>Chief Executive Officer Eddie Chng said the device combines AI algorithms with ease of use, delivering results in 10 seconds. The company aims to expand the device's reach regionally.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6057","symbol_name":"技术产品经销商","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2502808121","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2502808121","pubTimestamp":1736375817,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"DISA Limited's  subsidiary, Digital Life Line, has partnered with the National University Hospital  and the National University of Singapore to commercialize the Mobile Imaging Device for Anterior Segment , a portable cataract screening device, according to a Wednesday filing with the Tokyo Stock Exchange.The AI-powered tool, designed for use with smartphones, enables quick, community-based cataract detection, targeting early intervention, the filing said.Chief Executive Officer Eddie Chng said the device combines AI algorithms with ease of use, delivering results in 10 seconds. The company aims to expand the device's reach regionally.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6057":"技术产品经销商","532.SI":"鈞富集团有限公司","BK6508":"软件和IT服务概念"},"translate_title":"DISA签署人工智能白内障筛查设备商业化许可协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"532.SI":1},"content_text":"DISA Limited's (SGX:532) subsidiary, Digital Life Line, has partnered with the National University Hospital (Singapore) and the National University of Singapore to commercialize the Mobile Imaging Device for Anterior Segment (MIDAS), a portable cataract screening device, according to a Wednesday filing with the Tokyo Stock Exchange.The AI-powered tool, designed for use with smartphones, enables quick, community-based cataract detection, targeting early intervention, the filing said.Chief Executive Officer Eddie Chng said the device combines AI algorithms with ease of use, delivering results in 10 seconds. The company aims to expand the device's reach regionally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}